(0.22%) 5 192.20 points
(0.14%) 38 907 points
(0.11%) 16 367 points
(-0.36%) $78.20
(-0.05%) $2.19
(-0.10%) $2 328.90
(0.03%) $27.62
(1.91%) $983.30
(-0.08%) $0.928
(0.35%) $10.86
(0.02%) $0.796
(0.26%) $91.58
0.00% € 222.00
Live Chart Being Loaded With Signals
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents...
Stats | |
---|---|
Volumen de hoy | 736.00 |
Volumen promedio | 4 602.00 |
Capitalización de mercado | 17.24B |
EPS | €0 ( 2024-04-17 ) |
Próxima fecha de ganancias | ( €0 ) 2024-07-18 |
Last Dividend | €1.430 ( 2023-03-30 ) |
Next Dividend | €0 ( N/A ) |
P/E | 103.26 |
ATR14 | €1.429 (0.64%) |
Volumen Correlación
Sartorius AG Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sartorius AG Correlación - Moneda/Commodity
Sartorius AG Finanzas
Annual | 2023 |
Ingresos: | €3.40B |
Beneficio Bruto: | €1.57B (46.15 %) |
EPS: | €4.95 |
FY | 2023 |
Ingresos: | €3.40B |
Beneficio Bruto: | €1.57B (46.15 %) |
EPS: | €4.95 |
FY | 2022 |
Ingresos: | €4.17B |
Beneficio Bruto: | €2.20B (52.61 %) |
EPS: | €13.35 |
FY | 2021 |
Ingresos: | €3.45B |
Beneficio Bruto: | €1.84B (53.31 %) |
EPS: | €4.66 |
Financial Reports:
No articles found.
Sartorius AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€1.430 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.0600 | 2000-06-22 |
Last Dividend | €1.430 | 2023-03-30 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | €8.48 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.94 | -- |
Div. Sustainability Score | 9.59 | |
Div.Growth Potential Score | 5.00 | |
Div. Directional Score | 7.29 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TTK.DE | Ex Dividend Knight | 2023-05-25 | Annually | 0 | 0.00% | |
CWC.DE | Ex Dividend Knight | 2023-06-08 | Annually | 0 | 0.00% | |
MSF.DE | Ex Dividend Knight | 2023-08-16 | Quarterly | 0 | 0.00% | |
1YD.DE | Ex Dividend Knight | 2023-09-20 | Quarterly | 0 | 0.00% | |
XGR2.DE | Ex Dividend Junior | 2023-06-08 | Annually | 0 | 0.00% | |
ERCB.DE | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
PAT.DE | Ex Dividend Junior | 2023-05-26 | Sporadic | 0 | 0.00% | |
AEC1.DE | Ex Dividend Knight | 2023-07-06 | Quarterly | 0 | 0.00% | |
H5E.DE | No Dividend Player | 2023-07-10 | Annually | 0 | 0.00% | |
SBS.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0739 | 1.500 | 8.52 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0230 | 1.200 | 9.23 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.111 | 1.500 | 9.88 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.000409 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.02 | 0.800 | 4.88 | 3.90 | [1 - 3] |
quickRatioTTM | 1.193 | 0.800 | 7.69 | 6.15 | [0.8 - 2.5] |
cashRatioTTM | 0.803 | 1.500 | 6.65 | 9.97 | [0.2 - 2] |
debtRatioTTM | 0.479 | -1.500 | 2.02 | -3.04 | [0 - 0.6] |
interestCoverageTTM | 2.48 | 1.000 | -0.194 | -0.194 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.05 | 2.00 | 6.65 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.973 | 2.00 | 9.01 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.904 | -1.500 | 2.39 | -3.58 | [0 - 2.5] |
grossProfitMarginTTM | 0.451 | 1.000 | 5.81 | 5.81 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.150 | 1.000 | 8.99 | 8.99 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.135 | 1.000 | -0.360 | -0.360 | [0.2 - 2] |
assetTurnoverTTM | 0.312 | 0.800 | -1.256 | -1.005 | [0.5 - 2] |
Total Score | 9.59 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 62.07 | 1.000 | 3.83 | 0 | [1 - 100] |
returnOnEquityTTM | 0.111 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.973 | 2.00 | 9.34 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.329 | 1.500 | 1.779 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.05 | 2.00 | 6.65 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.000409 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0.120 | 1.500 | -2.53 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.208 | 1.000 | 7.31 | 0 | [0.1 - 0.5] |
Total Score | 5.00 |
Sartorius AG
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico